Grace Life-Tech Holdings Limited has announced significant steps in its ongoing restructuring process aimed at resolving its going concern issue. Since March 31, 2025, the company has focused on expanding its plant stem cell business by enhancing sales channels and seeking strategic supplier investments. Additionally, the company has implemented cost-saving measures, such as optimizing workforce efficiency and conducting remuneration reviews. Grace Life-Tech is also preparing a comprehensive debt restructuring proposal, including debt compromise and debt-to-equity conversion. The company is in talks with a private equity investment fund in Beijing to explore potential collaboration on restructuring plans. Furthermore, negotiations are underway with a potential strategic partner to enhance the company's business presence in China.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。